Health
Pharmaceutical Companies Lose Their Shine On The Stock Exchange. Profits Down In 3Q
The five stock-exchange listed companies in the pharmaceutical sector recorded profit declines in the third quarter. The three drug manufacturers, Antibiotice, Zentiva and Biofarm, also saw...
Romania Might Have Up To 20 Private Health Insurance Houses By 2013
Romania will have up to 20 private health insurance houses "fighting over clients" by 2013, said Cristian Vladescu, head of the National Public Health and Sanitary Management School, in the...
Romanian Health Ministry’s 2012 Budget To Be Set For Entire Year, Won’t Be Revised - Minister
The Romanian Health Ministry’s 2012 budget will be set for the entire year and will not be revised, Health Minister Ladislau Ritli said Wednesday.
Insurers Need At Least Half A Billion Euros To Take Part In Romania’s Healthcare Reform
Insurers should hike share capital by around EUR500 million, besides other expenses, to take part in Romania’s state healthcare reform, Frans van der Ent, general manager of insurance compan...
Healthcare Must Adapt To Aging Population – Minister
Romania's healthcare system must adapt first of all to the elderly population, which is growing, Health Minister Ladislau Ritli said Wednesday in the Romanian Healthcare Forum, organized by...
Farmaceutica Remedia Net Profit Rises 39% In January-September
Romanian pharmaceuticals supplier Farmaceutica Remedia Deva (RMAH.RO) Tuesday said its net profit rose 39% on the year to 4 million lei (EUR0.92 million) in the first nine months, on higher...
Zentiva Romania 9-Month Net Profit Down 27% To RON42M
Romanian pharmaceuticals company Zentiva Romania (SCD.RO) Tuesday said its net profit fell 27% to 41.9 million lei (EUR9.9 million) in the first nine months, from RON57.4 million in the year...
Actavis Romania Names Dan Ivan As General Manager
Pharmaceutical company Actavis appointed Dan Ivan as general manager of its Romanian operations, replacing Alina Culcea, who was appointed to the position of deputy general manager.
GlaxoSmithKline Completes $7M Investment At Brasov Plant
UK medicine maker GlaxoSmithKline (GSK) on Tuesday announced it has completed a $7 million investment in two production lines at the plant it owns in central Romanian city of Brasov..